BR112015011430A2 - composição para liberação imediata e prolongada - Google Patents
composição para liberação imediata e prolongadaInfo
- Publication number
- BR112015011430A2 BR112015011430A2 BR112015011430A BR112015011430A BR112015011430A2 BR 112015011430 A2 BR112015011430 A2 BR 112015011430A2 BR 112015011430 A BR112015011430 A BR 112015011430A BR 112015011430 A BR112015011430 A BR 112015011430A BR 112015011430 A2 BR112015011430 A2 BR 112015011430A2
- Authority
- BR
- Brazil
- Prior art keywords
- immediate
- composition
- prolonged release
- release
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3575DE2012 | 2012-11-21 | ||
IN3947DE2012 | 2012-12-20 | ||
PCT/EP2013/074373 WO2014079922A1 (en) | 2012-11-21 | 2013-11-21 | Composition for immediate and extended release |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015011430A2 true BR112015011430A2 (pt) | 2017-07-11 |
Family
ID=49619947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015011430A BR112015011430A2 (pt) | 2012-11-21 | 2013-11-21 | composição para liberação imediata e prolongada |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2922525A1 (ru) |
JP (1) | JP2016500088A (ru) |
KR (1) | KR20150085826A (ru) |
CN (1) | CN104797240A (ru) |
AR (1) | AR093585A1 (ru) |
AU (1) | AU2013349682A1 (ru) |
BR (1) | BR112015011430A2 (ru) |
CA (1) | CA2891365A1 (ru) |
EA (1) | EA201590805A1 (ru) |
HK (1) | HK1213779A1 (ru) |
IL (1) | IL238648A0 (ru) |
IN (1) | IN2015DN03984A (ru) |
MX (1) | MX2015006399A (ru) |
PH (1) | PH12015501096A1 (ru) |
SG (2) | SG10201703388TA (ru) |
TW (1) | TW201422254A (ru) |
WO (1) | WO2014079922A1 (ru) |
ZA (1) | ZA201503603B (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3024474B1 (en) | 2013-07-23 | 2022-01-05 | Serenity Pharmaceuticals LLC | Compositions comprising desmopressin in combination with a beta-3 adrenergic receptor agonist |
KR20150144209A (ko) * | 2014-06-16 | 2015-12-24 | 훼링 비.브이. | 안정화된 데스모프레신 또는 이의 약학적으로 허용가능한 염을 함유 약학 조성물 |
DK3220942T3 (da) * | 2014-11-20 | 2022-07-18 | Serenity Pharmaceuticals Llc | Sammensætninger omfattende lav dosis af desmopressin i kombination med en alpha-adrenerg receptorantagonist |
WO2016114812A1 (en) * | 2015-01-12 | 2016-07-21 | Robert Niichel | Layered sustained-release microbeads and methods of making the same |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
AU2016317092A1 (en) * | 2015-09-01 | 2018-04-26 | Wellesley Pharmaceuticals, Llc | Extended, delayed and immediate release formulation method of manufacturing and use thereof |
JP2018529711A (ja) * | 2015-09-30 | 2018-10-11 | ウェルズリー ファーマスーティカルズ、エルエルシー | 排尿の頻度を低減するための組成物、ならびにその作製および使用方法 |
WO2017058436A1 (en) * | 2015-09-30 | 2017-04-06 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
TW201726114A (zh) * | 2015-11-23 | 2017-08-01 | 魏斯理製藥公司 | 降低排尿頻率之組成物、其製備方法、及其應用 |
RU2018126368A (ru) * | 2015-12-18 | 2020-01-20 | УЭЛЛСЛИ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Композиция для уменьшения частоты мочеиспускания, способ ее получения и применение |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
MY195591A (en) | 2017-01-11 | 2023-02-02 | Ferring Bv | A Fast Disintegrating Pharmaceutical Composition |
KR20190021180A (ko) * | 2017-08-22 | 2019-03-05 | 아주대학교산학협력단 | 퇴행성 신경질환 치료용 복합 제형 조성물 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4052997A (en) | 1996-07-19 | 1998-02-10 | Clarke-Garegg, Margaret A. | Levan derivatives, their preparation, composition and applications including medical and food applications |
SE9803871D0 (sv) * | 1998-11-11 | 1998-11-11 | Pharmacia & Upjohn Ab | Therapeutic method and formulation |
GB9908014D0 (en) | 1999-04-08 | 1999-06-02 | Scherer Corp R P | Pharmaceutical compositions |
EP1064938A1 (en) * | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
US6509040B1 (en) | 2001-06-22 | 2003-01-21 | R.P. Scherer Corporation | Fast dispersing dosage forms essentially free of mammalian gelatin |
GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
CA2484724C (en) * | 2002-05-07 | 2007-01-16 | Ferring B.V. | Pharmaceutical formulations |
US8012505B2 (en) | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
CN100366294C (zh) | 2004-04-30 | 2008-02-06 | 量子高科(北京)研究院有限公司 | 一种口腔速溶制剂及其生产方法 |
EP1629834A1 (en) | 2004-08-27 | 2006-03-01 | KRKA, D.D., Novo Mesto | Sustained release pharmaceutical composition of tolterodine |
WO2007029087A2 (en) | 2005-09-05 | 2007-03-15 | Ranbaxy Laboratories Limited | Controlled release multiple unit formulations |
US20090192228A1 (en) | 2008-01-28 | 2009-07-30 | Actavis Group Ptc Ehf | Controlled-Release Tolterodine Compositions and Methods |
US20110217371A1 (en) * | 2008-11-10 | 2011-09-08 | Amorepacific Corporation | Controlled-release microparticles and method of preparing same |
WO2011013082A1 (en) * | 2009-07-31 | 2011-02-03 | Ranbaxy Laboratories Limited | Multi-layered, multiple unit pharmaceutical compositions |
RU2566269C2 (ru) * | 2010-03-29 | 2015-10-20 | Ферринг Б.В. | Быстрорастворимая фармацевтическая композиция |
JO3112B1 (ar) * | 2010-03-29 | 2017-09-20 | Ferring Bv | تركيبة دوائية سريعة التحلل |
MX356601B (es) * | 2010-03-30 | 2018-05-29 | Productos Maver S A De C V | Combinación farmacéutica con efecto antimigrañoso, en presentación sólida de liberación diferenciada. |
US20120135050A1 (en) * | 2010-07-08 | 2012-05-31 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
-
2013
- 2013-11-11 TW TW102140886A patent/TW201422254A/zh unknown
- 2013-11-21 IN IN3984DEN2015 patent/IN2015DN03984A/en unknown
- 2013-11-21 CN CN201380060349.8A patent/CN104797240A/zh active Pending
- 2013-11-21 KR KR1020157015219A patent/KR20150085826A/ko not_active Application Discontinuation
- 2013-11-21 EA EA201590805A patent/EA201590805A1/ru unknown
- 2013-11-21 CA CA2891365A patent/CA2891365A1/en not_active Abandoned
- 2013-11-21 JP JP2015543424A patent/JP2016500088A/ja active Pending
- 2013-11-21 EP EP13792703.4A patent/EP2922525A1/en not_active Withdrawn
- 2013-11-21 WO PCT/EP2013/074373 patent/WO2014079922A1/en active Application Filing
- 2013-11-21 MX MX2015006399A patent/MX2015006399A/es unknown
- 2013-11-21 SG SG10201703388TA patent/SG10201703388TA/en unknown
- 2013-11-21 SG SG11201503913TA patent/SG11201503913TA/en unknown
- 2013-11-21 BR BR112015011430A patent/BR112015011430A2/pt not_active Application Discontinuation
- 2013-11-21 AU AU2013349682A patent/AU2013349682A1/en not_active Abandoned
- 2013-11-21 AR ARP130104308A patent/AR093585A1/es unknown
-
2015
- 2015-05-05 IL IL238648A patent/IL238648A0/en unknown
- 2015-05-15 PH PH12015501096A patent/PH12015501096A1/en unknown
- 2015-05-21 ZA ZA2015/03603A patent/ZA201503603B/en unknown
-
2016
- 2016-02-18 HK HK16101745.8A patent/HK1213779A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2016500088A (ja) | 2016-01-07 |
CA2891365A1 (en) | 2014-05-30 |
AU2013349682A1 (en) | 2015-06-04 |
EP2922525A1 (en) | 2015-09-30 |
SG11201503913TA (en) | 2015-06-29 |
KR20150085826A (ko) | 2015-07-24 |
MX2015006399A (es) | 2015-07-21 |
CN104797240A (zh) | 2015-07-22 |
SG10201703388TA (en) | 2017-05-30 |
WO2014079922A1 (en) | 2014-05-30 |
AR093585A1 (es) | 2015-06-10 |
IN2015DN03984A (ru) | 2015-10-02 |
ZA201503603B (en) | 2016-01-27 |
EA201590805A1 (ru) | 2015-11-30 |
IL238648A0 (en) | 2015-06-30 |
HK1213779A1 (zh) | 2016-07-15 |
TW201422254A (zh) | 2014-06-16 |
PH12015501096A1 (en) | 2015-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015011430A2 (pt) | composição para liberação imediata e prolongada | |
BR112015022972A2 (pt) | composição farmacêutica de cloridrato de s-cetamina | |
BR112013031268A8 (pt) | polipeptídeos | |
MX2015008628A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
PE20151067A1 (es) | Inhibidores de autotaxina | |
PE20150092A1 (es) | Composiciones farmaceuticas que contienen fumarato de dimetilo | |
BR112015000578A2 (pt) | moduladores da via do complemento e usos dos mesmos | |
EA201690102A1 (ru) | Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе | |
BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
BR112014005025A2 (pt) | composição farmacêutica para uso no tratamento de uma doença neurodegenerativa | |
BR112012024673A2 (pt) | composição anestésica termogelificante | |
BR112013008601A8 (pt) | Formulações de emulsão de clevidipina contendo agentes antimicrobianos | |
CL2012001836A1 (es) | Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros. | |
CL2014003503A1 (es) | Composición farmacéutica para uso intramamario que comprende un ácido fosfónico y al menos un agente antimicrobiano; y uso para el tratamiento o prevención de mastitis en mamífero no humano. | |
UY33530A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias | |
PE20150353A1 (es) | Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparacion, preparaciones farmaceuticas que los contienen, asi como su uso para la preparacion de medicamentos | |
BR112014032759A2 (pt) | composições lipídicas de racecadotril | |
BR112015023387A2 (pt) | composições lipídicas de racecodotril | |
BR112013024824A2 (pt) | ésteres isopentílicos para uso em composições cosméticas, dermatológicas ou farmacêuticas | |
BR112017012406A2 (pt) | formulação com relação fixa de insulina glargina/lixisenatida | |
CU24163B1 (es) | Composición farmacéutica oftalmológica tópica que contiene regorafenib | |
MX2016001422A (es) | Composicion farmaceutica de fingolimod. | |
CL2016001094A1 (es) | Silicato de zirconio microporoso para el tratamiento de hipercalemia. | |
MX2016000294A (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |